Skip to main content
. 2023 Feb 7;18(2):e0281459. doi: 10.1371/journal.pone.0281459

Fig 2.

Fig 2

Comparisons of the ATB (+) and ATB (-) groups in terms of PFS (a) based on mRECIST and (b) based on RECIST v1.1. Abbreviations: ATB, antibiotics; RECIST v1.1, Response Evaluation Criteria in Solid Tumors version 1.1; mRECIST, modified RECIST; PFS, progression-free survival.